Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients-Reference-Cited by-同舟云学术

Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients

Published:2013-09-27 Issue:11 Volume:62 Page:1711-1722
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Jordan Kimberly R.,Amaria Rodabe N.,Ramirez Oscar,Callihan Eryn B.,Gao Dexiang,Borakove Michelle,Manthey Elizabeth,Borges Virginia F.,McCarter Martin D.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-013-1475-x.pdf

Reference50 articles.

1. Baumgartner JM, Gonzalez R, Lewis KD, Robinson WA, Richter DA, Palmer BE, Wilson CC, McCarter MD (2009) Increased survival from stage IV melanoma associated with fewer regulatory T Cells. J Surg Res 154:13–20

2. Cote AL, Usherwood EJ, Turk MJ (2008) Tumor-specific T-cell memory: clearing the regulatory T-cell hurdle. Cancer Res 68:1614–1617

3. Atkins MB, Lotze MT, Dutcher JP, Fisher RI, Weiss G, Margolin K, Abrams J, Sznol M, Parkinson D, Hawkins M et al (1999) High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol 17:2105–2116

4. Hodi FS, O’Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC et al (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363:711–723

5. Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD, Sosman JA, Atkins MB et al (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366:2443–2454

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determinants of resistance and response to melanoma therapy;Nature Cancer;2024-07-17

2. Advancing immunotherapy for melanoma: the critical role of single-cell analysis in identifying predictive biomarkers;Frontiers in Immunology;2024-07-04

3. Targeting myeloid-derived suppressor cells by inhibiting hypoxia-inducible factor 1α could improve tumor progression;Annals of Medicine & Surgery;2024-05-17

4. Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion;Experimental Hematology & Oncology;2024-04-12

5. Myeloid derived suppressor cells in peripheral blood can be a prognostic factor in canine transitional cell carcinoma;Veterinary Immunology and Immunopathology;2024-03